A recent petition calling for the decriminalization of cannabis in Poland has sparked a significant debate, with the Parliamentary Committee on Petitions sending a formal request to Prime Minister Donald Tusk for his consideration. This move signifies a potential shift in the country’s cannabis policy, prompting discussions about the potential impacts on young voters and the overall legal landscape.
Results for: Cannabis
The UK government has announced changes to simplify hemp farming regulations, allowing greater flexibility for licensed growers. While this is a positive step for the industry, the government has yet to address calls to raise the THC limit for industrial hemp or reduce licensing fees. Meanwhile, advocates continue to push for wider access to medical cannabis, highlighting its potential benefits and cost-effectiveness.
CBD of Denver, a leading cannabis company, has announced a delay in its German expansion plans due to ongoing market uncertainty. The company is awaiting regulatory approvals for its Grow Hub business model, while the overall German cannabis market faces challenges with slow licensing progress and bureaucratic hurdles.
MJBizCon 2024 in Las Vegas promises valuable insights from industry leaders. Two key panels featuring Benzinga Cannabis’ Javier Hasse will delve into crucial topics like brand building in the ancillary market and the evolving landscape of cannabis in Latin America. These sessions offer actionable knowledge for entrepreneurs and investors navigating the dynamic cannabis space.
The cannabis industry is facing significant turmoil following the 2024 elections, with investor concerns mounting over political uncertainty and the fallout from Florida’s failed legalization vote. This has led to a dramatic selloff in top U.S. and Canadian cannabis stocks. This article examines the potential justifications for the market downturn, analyzing the impact of the failed Florida vote and recent earnings reports from major players.
Auxly Cannabis Group Inc. (XLY, CBWTF) announced strong Q3 2024 financial results, driven by an 18% year-over-year increase in net revenue, reaching CA$33.3 million. The company also achieved a record adjusted EBITDA of CA$8.3 million, demonstrating its commitment to efficient growth and enhanced profitability.
Jaime Rengifo, CEO of Prich Biotech, the largest cannabis company in Latin America, believes Puerto Rico is a cannabis paradise. He credits the island’s functional regulatory system, focus on education, and commitment to accessibility for its success in the medicinal cannabis market. Rengifo highlights the potential for Puerto Rico to become a global leader in exporting high-quality medicinal cannabis, leveraging its existing pharmaceutical infrastructure and regulatory framework.
Six years after legalizing medical marijuana, families in the UK are demanding change as the NHS continues to fall short in providing access to life-saving cannabis-based medications. Parents of children suffering from treatment-resistant epilepsy are particularly vocal, citing the effectiveness of medical marijuana compared to conventional treatments. Despite legal access, only a handful of patients have received NHS prescriptions, leaving many families struggling to afford private options.
Leafly Holdings, the cannabis discovery marketplace, reported a revenue decline in Q3 2024 compared to the same period last year, attributing it to fewer retail accounts and budget constraints among customers. However, the company highlighted its efforts to stabilize its retail business and achieve positive adjusted EBITDA for two consecutive quarters. Leafly plans to capitalize on growth opportunities while focusing on cost efficiency and resolving its convertible notes due in January 2025.
This holiday season, consider incorporating cannabis into your family gatherings as a natural way to manage stress and promote a more peaceful atmosphere. Learn how microdosing THC gummies can help you stay calm, relaxed, and engaged with loved ones, even during potentially tense conversations.